Copyright Reports & Markets. All rights reserved.

Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update

Buy now

Table of Contents

    Table of Contents 2

      List of Tables 4

        List of Figures 4

          Co-Diagnostics Inc Company Overview 5

            Co-Diagnostics Inc Company Snapshot 5

              Co-Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

                Co-Diagnostics Inc – Pipeline Analysis Overview 8

                  Co-Diagnostics Inc - Key Facts 8

                    Co-Diagnostics Inc - Major Products and Services 9

                      Co-Diagnostics Inc Pipeline Products by Development Stage 10

                        Co-Diagnostics Inc Pipeline Products Overview 13

                          Co-Dx Test - Human Papillomavirus 13

                            Co-Dx Test - Human Papillomavirus Product Overview 13

                              Co-Dx Test - Gonorrhoea/Chlamydia 14

                                Co-Dx Test - Gonorrhoea/Chlamydia Product Overview 14

                                  Companion Diagnostic Test - Cancer 15

                                    Companion Diagnostic Test - Cancer Product Overview 15

                                      Diagnostic Test - Drug Resistant Tuberculosis 16

                                        Diagnostic Test - Drug Resistant Tuberculosis Product Overview 16

                                          Diagnostic Test - Heart Disease 17

                                            Diagnostic Test - Heart Disease Product Overview 17

                                              Diagnostic Test - Auto-immune Disorder 18

                                                Diagnostic Test - Auto-immune Disorder Product Overview 18

                                                  Diagnostic Test - Blood Bank Multiplex Test 19

                                                    Diagnostic Test - Blood Bank Multiplex Test Product Overview 19

                                                      Diagnostic Test - Genetic Disorder 20

                                                        Diagnostic Test - Genetic Disorder Product Overview 20

                                                          Diagnostic Test - Health Care-associated Infection 21

                                                            Diagnostic Test - Health Care-associated Infection Product Overview 21

                                                              Diagnostic Test - Hepatitis C 22

                                                                Diagnostic Test - Hepatitis C Product Overview 22

                                                                  Diagnostic Test - Infectious Disease 23

                                                                    Diagnostic Test - Infectious Disease Product Overview 23

                                                                      Diagnostic Test - Oncology 24

                                                                        Diagnostic Test - Oncology Product Overview 24

                                                                          Diagnostic Test - STD Panel 25

                                                                            Diagnostic Test - STD Panel Product Overview 25

                                                                              Diagnostic Test - Women's Health 26

                                                                                Diagnostic Test - Women's Health Product Overview 26

                                                                                  LightPCR 27

                                                                                    LightPCR Product Overview 27

                                                                                      Co-Diagnostics Inc - Key Competitors 28

                                                                                        Co-Diagnostics Inc - Key Employees 29

                                                                                          Co-Diagnostics Inc - Locations And Subsidiaries 30

                                                                                            Head Office 30

                                                                                              Other Locations & Subsidiaries 30

                                                                                                Joint Venture 30

                                                                                                  Recent Developments 31

                                                                                                    Co-Diagnostics Inc, Recent Developments 31

                                                                                                      Jul 17, 2018: Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test 31

                                                                                                        Jun 11, 2018: Co-Diagnostics to Host Booth at CARPHA Conference 31

                                                                                                          Jun 05, 2018: Co-Diagnostics Announces Advancement of Co-Primers Technology in Multiplex SNP Genotyping 32

                                                                                                            Jun 01, 2018: Co-Diagnostics Announces Participation in Research Project with Stanford University 32

                                                                                                              Mar 22, 2018: Co-Diagnostics Announces Construction Update at JV Manufacturing Facility in India 32

                                                                                                                Feb 28, 2018: Co-Diagnostics Announces Positive Results from Co-Primers Technology in Multiplex Tests for SNP Detection 33

                                                                                                                  Feb 21, 2018: Co-Diagnostics Ships Product to India for Validation Study 33

                                                                                                                    Dec 19, 2017: Co-Diagnostics Enters Into Lease for New, Upgraded Laboratory Facility 33

                                                                                                                      Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 34

                                                                                                                        Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 35

                                                                                                                          Appendix 36

                                                                                                                            Methodology 36

                                                                                                                              About GlobalData 39

                                                                                                                                Contact Us 39

                                                                                                                                  Disclaimer 39

                                                                                                                                  Summary

                                                                                                                                  Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

                                                                                                                                  This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

                                                                                                                                  The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

                                                                                                                                  Scope:

                                                                                                                                  - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
                                                                                                                                  - The report analyzes all pipeline products in development for the company Co-Diagnostics Inc
                                                                                                                                  - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
                                                                                                                                  - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
                                                                                                                                  - The report provides detailed description of products in development, technical specification and functions
                                                                                                                                  - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

                                                                                                                                  Reasons to Buy:

                                                                                                                                  - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
                                                                                                                                  - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
                                                                                                                                  - To formulate effective Research & Development strategies
                                                                                                                                  - Develop market-entry and market expansion strategies
                                                                                                                                  - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
                                                                                                                                  - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
                                                                                                                                  - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
                                                                                                                                  - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
                                                                                                                                  - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

                                                                                                                                  Note: Some sections may be missing if data is unavailable for the company

                                                                                                                                  Buy now